Core Scientific Stock Year Signals Pivot Data Center Growth
A large new stake underscores Core Scientific's shift toward data center services. This article breaks down the impli...
Ways To Pull In Cash Fast
Pulling in cash fast is possible with the right strategies. Learn effective methods to boost your income quickly.
21,139 articles
Gentherm (THRM) 2025 Earnings Outlook: Trends & Guidance
As EV demand rises, Gentherm faces an earnings path shaped by margins, backlog, and product mix. This guide breaks do...
Late Savers Struggle with Warren Buffett’s Index Fund Advice
A growing number of would-be investors miss Buffett’s simple path to wealth because they cannot save enough to invest...
Waiting Claim Social Security: Big Payoff Ahead for Retirees
Choosing when to claim Social Security isn’t just about age—it’s a strategy. Delaying benefits can lead to a larger l...
Is It Time Beaten-Down Salesforce? A Practical Buy Guide
Salesforce has seen its stock tumble as investors weigh AI bets and growth. This guide breaks down whether the beaten...
Will Spiking Prices Hurt Stocks? A Practical Investor Guide
Oil has jumped on geopolitical fears, and investors wonder how this could affect their portfolios. This guide explain...
Nvidia Sold Applied Digital: What It Means for Investors
When a tech behemoth trims a smaller stake, it prompts questions about risk, strategy, and opportunity. This guide ex...
Sells 6,799 Shares Qualys: What It Means for Investors Today
A top executive recently disclosed selling a sizable block of Qualys stock. This article explains how to interpret in...
Buying Archer Aviation (ACHR) Stock Could 10X Net Worth
Archer Aviation is venturing into urban air mobility with electric VTOL aircraft. This piece analyzes the case for bu...
Your April Social Security: What to Watch This Year
April Social Security payments arrive on a staggered schedule tied to birth dates. The 2.8% COLA is offset by Medicar...
Gold.com Board Director Sells: Lessons for Investors
A Gold.com board director sold a sizable stake as bullion endured its worst week in decades. This article explains wh...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status